Plasma rich in growth factors

DRUG8 trials

Conditions

Dry Eye DiseaseDry eye diseaseFoot ulcers in diabetic patients with peripheral arterial diseaseGlaucomaKnee OsteoarthritisLow Reserve OvarianLow back paingenitourinary syndrome of menopause

Phase 2

“Pilot, open, non-comparative study to evaluate the safety and efficacy of Factor-Rich Plasma Intraovarian Growth in Patients with Low Reserve Ovarian”

RecruitingCTIS2024-514444-87-00

Instituto De Investigacion Sanitaria Fundacion Jimenez DiazLow Reserve Ovarian

Start: 2025-05-29Target: 50Updated: 2024-11-13

Phase 3

Effect Of Plasma Rich In Growth Factors In Knee Osteoarthritis

CompletedNCT02039531

Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de AsturiasKnee Osteoarthritis

Start: 2011-08-31End: 2015-01-31Updated: 2015-05-05

Randomized, double-blind, parallel group clinical trial to evaluate the efficacy and safety of PRGF eye drops as a treatment for dry eye disease in patients with glaucoma

RecruitingCTIS2024-519460-40-00

Biotechnology Institute I Mas D S.L.Dry eye disease, Glaucoma

Start: 2022-11-08Target: 70Updated: 2024-11-28

Phase 4

The efficacy of the use of Cellular Matrix-BCT-HA (combination of autologous platelet-rich plasma and non-cross-linked hyaluronic acid) compared to local estrogen therapy (Blissel, estriol 50 micrograms/g vaginal gel) in women with genitourinary syndrome of menopause. A randomized controlled trial, with a second blind observer.

RecruitingCTIS2023-507200-31-00

Santiago Dexeus Font Fundacio Privadagenitourinary syndrome of menopause

Start: 2024-05-24Target: 192Updated: 2025-05-15

Randomized clinical trial, controlled with conventional treatment to evaluate the efficacy of Plasma Rich in Growth Factors (PRGF) in the treatment of foot ulcers in diabetic patients

RecruitingCTIS2023-504275-24-01

Biotechnology Institue I Mas D S.L.Foot ulcers in diabetic patients with peripheral arterial disease

Start: 2024-10-24Target: 38Updated: 2025-09-11

Randomized, parallel-group, double-blind clinical trial to evaluate the efficacy and safety of PRGF eye drops in patients with dry eye disease

WithdrawnCTIS2023-507357-15-00

Biotechnology Institue I Mas D S.L.Dry Eye Disease

Target: 54Updated: 2024-08-26

Multicenter, randomized, double-blind, controlled clinical trial to evaluate the safety and efficacy of PRGF-Endoret® infiltrations in the treatment of low back pain

RecruitingCTIS2023-507429-41-00

Biotechnology Institue I Mas D S.L.Low back pain

Start: 2024-12-26Target: 48Updated: 2025-03-03